FindTrial
Sign In

Clinical efficacy study of brain-computer interface technology in the regulation of urinary and fecal functions in patients with spinal cord injury

Clinical efficacy study of brain-computer interface technology in the regulation of urinary and fecal functions in patients with spinal cord injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108684
Enrollment
Unknown
Registered
2025-09-03
Start date
2025-09-10
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurogenic bowel dysfunction and neurogenic lower urinary tract dysfunction caused by spinal cord injury

Interventions

Control Group:Posterior tibial nerve electrical stimulation
BCI Group:Rehabilitation training of brain-computer interface for urination and defecation

Sponsors

Shandong Provincial Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Age 18-75 years, gender-neutral; 2.Spinal cord injury patients with incontinence symptoms; 3.Patients with incomplete suprasacral spinal cord injury, graded as B, C, and D according to the American Spinal Injury Association (ASIA) classification; 4.No significant cognitive impairment (MMSE illiteracy > 17 points, primary education > 20 points, junior high school and above > 24 points); 5.Signing the Informed Consent Form.

Exclusion criteria

Exclusion criteria: 1.Use of drugs affecting muscle tone, such as botulinum toxin injections and baclofen pump implantation, within the past month; 2.Patients with internal fixation for non - union fractures; 3.Patients with bone and joint tumors; 4.Individuals with scalp and skin surface lesions; 5.Individuals with metallic implants in the cranial cavity; 6.Hemispatial neglect or hemianopia; 7.Pregnant and lactating women; 8.Unstable angina, coronary stent implantation within the past six months, and patients with cardiac pacemaker implantation; 9.The researchers believe that individuals with other conditions deemed unsuitable for participation in this clinical trial; 10.Individuals who have participated in or are currently participating in other clinical trials within the three months prior to signing the informed consent form.

Design outcomes

Primary

MeasureTime frame
Neurogenic Bladder Symptom Score,NBSS;Neurogenic Bowel Dysfunction Score, NBD/NBDS;—

Secondary

MeasureTime frame
Bristol Stool Form Scale;Cystometry examination;Voiding diary;—

Countries

China

Contacts

Public ContactJie Jia

Huashan Hospital, Fudan University

shannonjj@126.com+86 21 52887820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026